{
  "data": {
    "id": "org_roche",
    "slug": "roche",
    "name": "Roche",
    "short_name": "Roche",
    "type": "company",
    "tier": 3,
    "homepage": "https://www.roche.com",
    "country_code": "CH",
    "reliability_note": null,
    "url": "https://statorigin.org/sources/roche",
    "documents": [
      {
        "title": "U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments",
        "url": "https://www.roche.com/media/releases/med-cor-2026-09-10",
        "doc_type": "press_release",
        "published_date": "2026-09-10",
        "accessed_at": "2026-09-15",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 2
      },
      {
        "title": "Roche’s US subsidiary Genentech announces manufacturing expansion in the United States",
        "url": "https://www.roche.com/media/releases/med-cor-2026-08-20",
        "doc_type": "press_release",
        "published_date": "2026-08-20",
        "accessed_at": "2026-09-15",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 4
      },
      {
        "title": "[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant a...",
        "url": "https://www.roche.com/media/releases/med-cor-2026-07-23",
        "doc_type": "press_release",
        "published_date": "2026-07-23",
        "accessed_at": "2026-09-15",
        "license": "see-source",
        "url_status": "ok",
        "statistic_count": 0
      }
    ],
    "statistics": [
      {
        "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGD9",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGD9",
        "indicator": {
          "slug": "countries-with-drug-approval",
          "name": "Countries with drug approval",
          "definition": "Number of countries in which a medicine has been granted regulatory approval for a given indication."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GLOBAL",
          "name": "Global",
          "type": "world"
        },
        "period": {
          "start": "2026-09-10",
          "end": "2026-09-10",
          "type": "point"
        },
        "value": 90,
        "value_text": "approximately 90",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Roche",
          "org_short_name": "Roche",
          "org_url": "https://www.roche.com",
          "org_tier": 3,
          "document_title": "U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments",
          "document_url": "https://www.roche.com/media/releases/med-cor-2026-09-10",
          "document_type": "press_release",
          "locator": "About Enspryng (satralizumab)",
          "quote": "Enspryng is the first and only IL-6 inhibitor treatment currently approved in approximately 90 countries for neuromyelitis optica spectrum disorder (NMOSD), including in the U.S. and E.U., with a well-established safety profile in over 10,000 patients.",
          "evidence_type": "quote",
          "dataset_query": null,
          "dataset_evidence": null,
          "published_date": "2026-09-10",
          "accessed_at": "2026-09-15",
          "license": "see-source",
          "url_status": "ok",
          "self_reported": true
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-15T22:15:46.809Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Roche. (2026). U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments. Retrieved September 15, 2026, from https://www.roche.com/media/releases/med-cor-2026-09-10. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGD9",
          "bibtex": "@misc{roche2026countriesbjmgd9,\n  author       = {{Roche}},\n  title        = {U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGD9},\n  note         = {Original source: https://www.roche.com/media/releases/med-cor-2026-09-10. Accessed September 15, 2026.}\n}"
        },
        "updated_at": "2026-09-27T15:32:06.228Z"
      },
      {
        "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGDA",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGDA",
        "indicator": {
          "slug": "patients-treated-with-drug",
          "name": "Patients treated with drug",
          "definition": "Cumulative number of patients in whom a medicine has an established safety profile through clinical trials and post-approval use."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GLOBAL",
          "name": "Global",
          "type": "world"
        },
        "period": {
          "start": "2026-09-10",
          "end": "2026-09-10",
          "type": "point"
        },
        "value": 10000,
        "value_text": "over 10,000",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Roche",
          "org_short_name": "Roche",
          "org_url": "https://www.roche.com",
          "org_tier": 3,
          "document_title": "U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments",
          "document_url": "https://www.roche.com/media/releases/med-cor-2026-09-10",
          "document_type": "press_release",
          "locator": "About Enspryng (satralizumab)",
          "quote": "Enspryng is the first and only IL-6 inhibitor treatment currently approved in approximately 90 countries for neuromyelitis optica spectrum disorder (NMOSD), including in the U.S. and E.U., with a well-established safety profile in over 10,000 patients.",
          "evidence_type": "quote",
          "dataset_query": null,
          "dataset_evidence": null,
          "published_date": "2026-09-10",
          "accessed_at": "2026-09-15",
          "license": "see-source",
          "url_status": "ok",
          "self_reported": true
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-15T22:15:46.809Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Roche. (2026). U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments. Retrieved September 15, 2026, from https://www.roche.com/media/releases/med-cor-2026-09-10. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGDA",
          "bibtex": "@misc{roche2026patientsbjmgda,\n  author       = {{Roche}},\n  title        = {U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGDA},\n  note         = {Original source: https://www.roche.com/media/releases/med-cor-2026-09-10. Accessed September 15, 2026.}\n}"
        },
        "updated_at": "2026-09-27T15:32:06.228Z"
      },
      {
        "id": "stat_XWVEPWH8A86STY8FSVZYJZ1WDN",
        "url": "https://statorigin.org/stat/stat_XWVEPWH8A86STY8FSVZYJZ1WDN",
        "indicator": {
          "slug": "company-countries-of-operation",
          "name": "Company countries of operation",
          "definition": "Total number of countries in which a healthcare company supplies and distributes pharmaceutical or diagnostic products."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "GLOBAL",
          "name": "Global",
          "type": "world"
        },
        "period": {
          "start": "2026-08-20",
          "end": "2026-08-20",
          "type": "point"
        },
        "value": 150,
        "value_text": "over 150",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Roche",
          "org_short_name": "Roche",
          "org_url": "https://www.roche.com",
          "org_tier": 3,
          "document_title": "Roche’s US subsidiary Genentech announces manufacturing expansion in the United States",
          "document_url": "https://www.roche.com/media/releases/med-cor-2026-08-20",
          "document_type": "press_release",
          "locator": "About Roche",
          "quote": "Roche was founded in Basel, Switzerland in 1896 and today is a leading provider of transformative medicines and diagnostics for millions of people in over 150 countries around the world.",
          "evidence_type": "quote",
          "dataset_query": null,
          "dataset_evidence": null,
          "published_date": "2026-08-20",
          "accessed_at": "2026-09-15",
          "license": "see-source",
          "url_status": "ok",
          "self_reported": true
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Roche. (2026). Roche’s US subsidiary Genentech announces manufacturing expansion in the United States. Retrieved September 15, 2026, from https://www.roche.com/media/releases/med-cor-2026-08-20. Via StatOrigin, https://statorigin.org/stat/stat_XWVEPWH8A86STY8FSVZYJZ1WDN",
          "bibtex": "@misc{roche2026companyjz1wdn,\n  author       = {{Roche}},\n  title        = {Roche’s US subsidiary Genentech announces manufacturing expansion in the United States},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_XWVEPWH8A86STY8FSVZYJZ1WDN},\n  note         = {Original source: https://www.roche.com/media/releases/med-cor-2026-08-20. Accessed September 15, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_F34RHKHZS2FXGR5VF26CT43Z3Z",
        "url": "https://statorigin.org/stat/stat_F34RHKHZS2FXGR5VF26CT43Z3Z",
        "indicator": {
          "slug": "company-operating-locations",
          "name": "Company operating locations",
          "definition": "Total number of distinct operational locations maintained by a pharmaceutical company."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2026-08-20",
          "end": "2026-08-20",
          "type": "point"
        },
        "value": 24,
        "value_text": "24",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "actual",
        "source": {
          "org": "Roche",
          "org_short_name": "Roche",
          "org_url": "https://www.roche.com",
          "org_tier": 3,
          "document_title": "Roche’s US subsidiary Genentech announces manufacturing expansion in the United States",
          "document_url": "https://www.roche.com/media/releases/med-cor-2026-08-20",
          "document_type": "press_release",
          "locator": "Roche’s US subsidiary Genentech announces manufacturing expansion in the United States",
          "quote": "Roche and Genentech’s current U.S. footprint includes 13 manufacturing sites, 15 research and development sites and approximately 25,000 employees across 24 locations in eight states.",
          "evidence_type": "quote",
          "dataset_query": null,
          "dataset_evidence": null,
          "published_date": "2026-08-20",
          "accessed_at": "2026-09-15",
          "license": "see-source",
          "url_status": "ok",
          "self_reported": true
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-17T07:16:01.811Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Roche. (2026). Roche’s US subsidiary Genentech announces manufacturing expansion in the United States. Retrieved September 15, 2026, from https://www.roche.com/media/releases/med-cor-2026-08-20. Via StatOrigin, https://statorigin.org/stat/stat_F34RHKHZS2FXGR5VF26CT43Z3Z",
          "bibtex": "@misc{roche2026companyt43z3z,\n  author       = {{Roche}},\n  title        = {Roche’s US subsidiary Genentech announces manufacturing expansion in the United States},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_F34RHKHZS2FXGR5VF26CT43Z3Z},\n  note         = {Original source: https://www.roche.com/media/releases/med-cor-2026-08-20. Accessed September 15, 2026.}\n}"
        },
        "updated_at": "2026-09-17T07:16:01.811Z"
      },
      {
        "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGET",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGET",
        "indicator": {
          "slug": "pharmaceutical-corporate-employment",
          "name": "Pharmaceutical corporate employment",
          "definition": "Total number of employees working for a pharmaceutical company within a specified region."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2026-08-20",
          "end": "2026-08-20",
          "type": "point"
        },
        "value": 25000,
        "value_text": "25,000",
        "unit": "count",
        "currency": null,
        "scale": "1",
        "value_type": "estimate",
        "source": {
          "org": "Roche",
          "org_short_name": "Roche",
          "org_url": "https://www.roche.com",
          "org_tier": 3,
          "document_title": "Roche’s US subsidiary Genentech announces manufacturing expansion in the United States",
          "document_url": "https://www.roche.com/media/releases/med-cor-2026-08-20",
          "document_type": "press_release",
          "locator": "Roche’s US subsidiary Genentech announces manufacturing expansion in the United States",
          "quote": "Roche and Genentech’s current U.S. footprint includes 13 manufacturing sites, 15 research and development sites and approximately 25,000 employees across 24 locations in eight states.",
          "evidence_type": "quote",
          "dataset_query": null,
          "dataset_evidence": null,
          "published_date": "2026-08-20",
          "accessed_at": "2026-09-15",
          "license": "see-source",
          "url_status": "ok",
          "self_reported": true
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-15T22:15:46.809Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Roche. (2026). Roche’s US subsidiary Genentech announces manufacturing expansion in the United States. Retrieved September 15, 2026, from https://www.roche.com/media/releases/med-cor-2026-08-20. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGET",
          "bibtex": "@misc{roche2026pharmaceuticalbjmget,\n  author       = {{Roche}},\n  title        = {Roche’s US subsidiary Genentech announces manufacturing expansion in the United States},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGET},\n  note         = {Original source: https://www.roche.com/media/releases/med-cor-2026-08-20. Accessed September 15, 2026.}\n}"
        },
        "updated_at": "2026-09-15T22:15:46.809Z"
      },
      {
        "id": "stat_01M2KJ7XCG3Y4BJ2059JBJMGEP",
        "url": "https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGEP",
        "indicator": {
          "slug": "pharmaceutical-manufacturing-facility-capital-investment",
          "name": "Pharmaceutical manufacturing facility capital investment",
          "definition": "Total planned capital expenditure and investment in pharmaceutical manufacturing and fill-finish facilities."
        },
        "industry": [
          {
            "slug": "pharmaceuticals",
            "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations",
            "isic": "C21",
            "is_primary": true
          }
        ],
        "region": {
          "code": "US",
          "name": "United States",
          "type": "country"
        },
        "period": {
          "start": "2026-08-20",
          "end": "2026-08-20",
          "type": "point"
        },
        "value": 750,
        "value_text": "Approximately $750 million",
        "unit": "USD",
        "currency": "USD",
        "scale": "million",
        "value_type": "forecast",
        "source": {
          "org": "Roche",
          "org_short_name": "Roche",
          "org_url": "https://www.roche.com",
          "org_tier": 3,
          "document_title": "Roche’s US subsidiary Genentech announces manufacturing expansion in the United States",
          "document_url": "https://www.roche.com/media/releases/med-cor-2026-08-20",
          "document_type": "press_release",
          "locator": "Roche’s US subsidiary Genentech announces manufacturing expansion in the United States",
          "quote": "Approximately $750 million investment will double the size of the existing facility and is expected to create an additional 250 specialised manufacturing jobs.",
          "evidence_type": "quote",
          "dataset_query": null,
          "dataset_evidence": null,
          "published_date": "2026-08-20",
          "accessed_at": "2026-09-15",
          "license": "see-source",
          "url_status": "ok",
          "self_reported": true
        },
        "verification": "verified",
        "verified_by": "seed:auto-extract-v1",
        "verified_at": "2026-09-15T22:15:46.809Z",
        "confidence": 0.9,
        "is_secondhand": false,
        "supersedes": null,
        "superseded_by": null,
        "is_current": true,
        "citation": {
          "apa": "Roche. (2026). Roche’s US subsidiary Genentech announces manufacturing expansion in the United States. Retrieved September 15, 2026, from https://www.roche.com/media/releases/med-cor-2026-08-20. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGEP",
          "bibtex": "@misc{roche2026pharmaceuticalbjmgep,\n  author       = {{Roche}},\n  title        = {Roche’s US subsidiary Genentech announces manufacturing expansion in the United States},\n  year         = {2026},\n  howpublished = {StatOrigin, https://statorigin.org},\n  url          = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGEP},\n  note         = {Original source: https://www.roche.com/media/releases/med-cor-2026-08-20. Accessed September 15, 2026.}\n}"
        },
        "updated_at": "2026-09-27T15:32:06.228Z"
      }
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 6,
    "note": "Statistics are capped at 100 per request. Use /statistics?source_org=roche with a cursor to page through everything."
  }
}